Cargando…

The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression

BACKGROUND: Downregulation of epithelial markers and upregulation of mesenchymal markers are the characteristics of the epithelial to mesenchymal transition (EMT) program, which provides the metastatic advantage of breast cancer. However, the mechanism underlying the switch of EMT markers remains po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jianchao, Fan, Xiaokai, Zhou, Yunfan, Chen, Liang, Rao, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164399/ https://www.ncbi.nlm.nih.gov/pubmed/35655230 http://dx.doi.org/10.1186/s13046-022-02400-7

Ejemplares similares

Dysregulated YY1/PRMT5 axis promotes the progression and metastasis of laryngeal cancer by targeting Hippo pathway
por: Wang, Nan, et al.
Publicado: (2020)

PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression
por: Liu, Ming, et al.
Publicado: (2020)

Jazf1 promotes prostate cancer progression by activating JNK/Slug
por: Sung, Yonghun, et al.
Publicado: (2017)

Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p/ PRMT5 axis
por: Jiang, Weihua, et al.
Publicado: (2023)

SLUG Manual - SLUG Interface to GEANT
por: DeWolf, R S
Publicado: (1993)

LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing
por: Le Douce, Valentin, et al.
Publicado: (2012)

LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing
por: Douce, Valentin Le, et al.
Publicado: (2014)

Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells
por: Huang, Tze-Sing, et al.
Publicado: (2014)

Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer
por: Hartley, Antja-Voy, et al.
Publicado: (2020)

PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma
por: Wang, Nan, et al.
Publicado: (2020)

The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma
por: Wright, Tanner, et al.
Publicado: (2021)

Aurora-A Regulates Progression and Metastasis of Colorectal Cancer by Promoting Slug Activity
por: He, Jin-Guang, et al.
Publicado: (2016)

SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
por: Uygur, Berna, et al.
Publicado: (2011)

HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA/Slug axis
por: Zheng, Lisha, et al.
Publicado: (2022)

PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast
por: Zhi, Renyong, et al.
Publicado: (2023)

Dual roles of myocardin-related transcription factors in epithelial–mesenchymal transition via slug induction and actin remodeling
por: Morita, Tsuyoshi, et al.
Publicado: (2007)

Fascin Is Regulated by Slug, Promotes Progression of Pancreatic Cancer in Mice, and Is Associated With Patient Outcomes
por: Li, Ang, et al.
Publicado: (2014)

YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD
por: Yu, Mengxue, et al.
Publicado: (2018)

Slug promoted vasculogenic mimicry in hepatocellular carcinoma
por: Sun, Dan, et al.
Publicado: (2013)

The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma
por: Zhang, Ke-jun, et al.
Publicado: (2010)

LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
por: Xie, Qiubo, et al.
Publicado: (2020)

Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer
por: Gajendran, Chandru, et al.
Publicado: (2023)

LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors
por: Egolf, Shaun, et al.
Publicado: (2019)

PRMT5 promotes epithelial‐mesenchymal transition via EGFR‐β‐catenin axis in pancreatic cancer cells
por: Ge, Lu, et al.
Publicado: (2019)

Akt3 promotes cancer stemness in triple-negative breast cancer through YB1-Snail/Slug signaling axis
por: Tian, Ye, et al.
Publicado: (2022)

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice
por: Prakasam, Ramachandran, et al.
Publicado: (2023)

ERα suppresses slug expression directly by transcriptional repression
por: Ye, Yin, et al.
Publicado: (2008)

Role of Slug transcription factor in human mesenchymal stem cells
por: Torreggiani, Elena, et al.
Publicado: (2012)

Role of the Slug Transcription Factor in Chemically-Induced Skin Cancer
por: von Maltzan, Kristine, et al.
Publicado: (2016)

Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer
por: Jiang, Ziwei, et al.
Publicado: (2021)

Dependency of NELF-E-SLUG-KAT2B epigenetic axis in breast cancer carcinogenesis
por: Zhang, Jieqiong, et al.
Publicado: (2023)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
por: Malbeteau, Lucie, et al.
Publicado: (2020)

Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression
por: Pan, Yi, et al.
Publicado: (2016)

miR‐708/LSD1 axis regulates the proliferation and invasion of breast cancer cells
por: Ma, Lin, et al.
Publicado: (2016)

Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling
por: Wang, Jiyin, et al.
Publicado: (2022)

Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
por: Hing, Zachary A., et al.
Publicado: (2023)

MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
por: Sun, Yan, et al.
Publicado: (2023)

NUAK1 promotes tumor metastasis through upregulating slug transcription in esophageal squamous cell carcinoma
por: Yang, Huiru, et al.
Publicado: (2023)

DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression
por: Wu, Jia-En, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eftrbb0lsua3ctvj2qq7p938ok